New mild and simple approach to isothiocyanates: A class of potent anticancer agents

Molecules

Volumn 22, Issue 6, 2017, Pages

  Luo, Bingling ^a,b   Wang, Jiankang ^a,b   Li, Xiaobing ^a   Lu, Wenhua ^a   Yang, Jing ^a   Hu, Yumin ^a   Huang, Peng ^a,b   Wen, Shijun ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Anticancer; Glutathione; Isothiocyanate; Reactive oxygen species

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTATHIONE; ISOTHIOCYANIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; HUMAN; METABOLISM; OXIDATIVE STRESS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; HUMANS; ISOTHIOCYANATES; MOLECULAR STRUCTURE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 85020813603     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22060773     Document Type: Article

References (28)

1. Ferguson, L.R.; Philpott, M. Cancer prevention by dietary bioactive components that target the immune response. Curr. Cancer Drug Targets 2007, 7, 459-464.
2. Cheung, K.L.; Khor, T.O.; Huang, M.T.; Kong, A.N. Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM. Carcinogenesis 2010, 31, 880-885.
3. Hu, R.; Kim, B.R.; Chen, C.; Hebbar, V.; Kong, A.N. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 2003, 24, 1361-1367.
4. Xiao, D.; Powolny, A.A.; Moura, M.B.; Kelley, E.E.; Bommareddy, A.; Kim, S.H.; Hahm, E.R.; Normolle, D.; Van Houten, B.; Singh, S.V. Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J. Biol. Chem. 2010, 285, 26558-26569.
5. Runarsdottir, A.; Mannervik, B. A novel quasi-species of glutathione transferase with high activity towards naturally occurring isothiocyanates evolves from promiscuous low-activity variants. J. Mol. Biol. 2010, 401, 451-464.
6. Syed Alwi, S.S.; Cavell, B.E.; Donlevy, A.; Packham, G. Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent. Cell Stress Chaperones 2012, 17, 529-538.
7. Yeomans, A.; Lemm, E.; Wilmore, S.; Cavell, B.E.; Valle-Argos, B.; Krysov, S.; Hidalgo, M.S.; Leonard, E.; Willis, A.E.; Forconi, F.; et al. PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2alpha phosphorylation in established cell lines and primary human leukemia cells. Oncotarget 2016, 7, 74807-74819.
8. Cavell, B.E.; Syed Alwi, S.S.; Donlevy, A.M.; Proud, C.G.; Packham, G. Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2. J. Nat. Prod. 2012, 75, 1051-1057.
9. Wang, X.; Di Pasqua, A.J.; Govind, S.; McCracken, E.; Hong, C.; Mi, L.; Mao, Y.; Wu, J.Y.; Tomita, Y.; Woodrick, J.C.; et al. Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships. J. Med. Chem. 2011, 54, 809-816.
10. Chen, G.; Chen, Z.; Hu, Y.; Huang, P. Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by beta-phenethyl isothiocyanate: mechanisms for anti-leukemia activity. Antioxid. Redox Signal. 2011, 15, 2911-2921.
11. Trachootham, D.; Zhang, H.; Zhang, W.; Feng, L.; Du, M.; Zhou, Y.; Chen, Z.; Pelicano, H.; Plunkett, W.; Wierda, W.G.; et al. Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood 2008, 112, 1912-1922.
12. Trachootham, D.; Zhou, Y.; Zhang, H.; Demizu, Y.; Chen, Z.; Pelicano, H.; Chiao, P.J.; Achanta, G.; Arlinghaus, R.B.; Liu, J.; et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006, 10, 241-252.
13. Mays, J.R.; Weller Roska, R.L.; Sarfaraz, S.; Mukhtar, H.; Rajski, S.R. Identification, synthesis, and enzymology of non-natural glucosinolate chemopreventive candidates. ChemBioChem 2008, 9, 729-747.
14. Vermeulen, M.; Zwanenburg, B.; Chittenden, G.J.; Verhagen, H. Synthesis of isothiocyanate-derived mercapturic acids. Eur. J. Med. Chem. 2003, 38, 729-737.
15. Berglund, M.; Dalence-Guzman, M.F.; Skogvall, S.; Sterner, O. SAR studies of capsazepinoid bronchodilators 3: The thiourea part (coupling region) and the 2-(4-chlorophenyl)ethyl moiety (C-region). Bioorg. Med. Chem. 2008, 16, 2529-2540.
16. Tsogoeva, S.B.; Hateley, M.J.; Yalalov, D.A.; Meindl, K.; Weckbecker, C.; Huthmacher, K. Thiourea-based non-nucleoside inhibitors of HIV reverse transcriptase as bifunctional organocatalysts in the asymmetric Strecker synthesis. Bioorg. Med. Chem. 2005, 13, 5680-5685.
17. Isobe, T.; Ishikawa, T. 2-Chloro-1, 3-dimethylimidazolinium chloride. 2. Its application to the construction of heterocycles through dehydration reactions. J. Org. Chem. 1999, 64, 6989-6992.
18. Munch, H.; Hansen, J.S.; Pittelkow, M.; Christensen, J.B.; Boas, U. A new efficient synthesis of isothiocyanates from amines using di-tert-butyl dicarbonate. Tetrahedron Lett. 2008, 49, 3117-3119.
19. Wong, R.; Dolman, S.J. Isothiocyanates from tosyl chloride mediated decomposition of in situ generated dithiocarbamic acid salts. J. Org. Chem. 2007, 72, 3969-3971.
20. Maisonneuve, P.; Lowenfels, A.B. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int. J. Epidemiol. 2015, 44, 186-198.
21. Von Hoff, D.D.; Ervin, T.; Arena, F.P.; Chiorean, E.G.; Infante, J.; Moore, M.; Seay, T.; Tjulandin, S.A.; Ma, W.W.; Saleh, M.N.; et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 2013, 369, 1691-1703.
22. Leung, W.K.; Wu, M.S.; Kakugawa, Y.; Kim, J.J.; Yeoh, K.G.; Goh, K.L.; Wu, K.C.; Wu, D.C.; Sollano, J.; Kachintorn, U.; et al. Screening for gastric cancer in Asia: Current evidence and practice. Lancet Oncol. 2008, 9, 279-287.
23. Zhang, E.B.; Han, L.; Yin, D.D.; Kong, R.; De, W.; Chen, J. C-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med. Oncol. 2014, 31, 914.
24. Li, D.; Xie, K.; Wolff, R.; Abbruzzese, J.L. Pancreatic cancer. Lancet 2004, 363, 1049-1057.
25. Raj, L.; Ide, T.; Gurkar, A.U.; Foley, M.; Schenone, M.; Li, X.; Tolliday, N.J.; Golub, T.R.; Carr, S.A.; Shamji, A.F.; et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011, 475, 231-234.
26. Trachootham, D.; Lu, W.; Ogasawara, M.A.; Nilsa, R.D.; Huang, P. Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10, 1343-1374.
27. Franco, R.; Cidlowski, J.A. Apoptosis and glutathione: Beyond an antioxidant. Cell Death Differ. 2009, 16, 1303-1314.
28. Chiang, Y.T.; Yen, Y.W.; Lo, C.L. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer. Biomaterials 2015, 61, 150-161.